PULL — Pure Extracts Technologies Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual income statement for Pure Extracts Technologies, fiscal year end - June 30th, CAD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2021 June 30th | 2022 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | fx Final | fx Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0.102 | 1.23 |
Cost of Revenue | |||||
Gross Profit | — | — | — | -0.058 | 0.128 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.073 | 0.114 | 0.079 | 20.5 | 6.51 |
Operating Profit | -0.073 | -0.114 | -0.079 | -20.4 | -5.28 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.088 | -0.114 | -0.079 | -20.7 | -5.24 |
Net Income After Taxes | -0.088 | -0.114 | -0.079 | -20.7 | -5.24 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 0.68 | -0.114 | -0.079 | -20.7 | -5.24 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.68 | -0.114 | -0.079 | -20.7 | -5.24 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.036 | -0.028 | -0.006 | -0.27 | -0.049 |